ArticleJournal of cell communication and signaling2026
Human brain pericytes protect the blood-brain barrier from triple-negative breast cancer cells while promoting tumor aggressiveness.
Article in Journal of cell communication and signaling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Human brain pericytes protect the blood-brain barrier from triple-negative breast cancer cells while promoting tumor aggressiveness.Journal of cell communication and signaling · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The majority of breast cancer-related deaths result from metastatic progression, especially brain metastasis, associated with the poorest prognosis. Patients with triple-negative breast cancer (TNBC) are particularly prone to developing brain metastases. In this context, the blood-brain barrier (BBB) plays a pivotal role; however, the contribution of brain pericytes in mediating interactions between TNBC cells and the brain endothelial cells (ECs) remains unclear. To investigate the role of pericytes in modulating these interactions, we used a syngeneic human in vitro BBB model, composed of human brain-like endothelial cells (hBLECs) co-cultured with human brain pericytes (hBPs). Our findings demonstrate that hBPs secretions significantly reduce TNBC cell adhesion to hBLECs and protect the endothelium from TNBC cell-induced damage, both under normoxic and hypoxic conditions. Interestingly, we found that hBPs promote TNBC cell migration, invasion, and increase clonogenicity. Together, these findings uncover a dual role of brain pericytes in TNBC brain metastasis: they protect ECs and maintain BBB integrity against TNBC cells while simultaneously promoting tumor aggressiveness. Understanding this balance between protective and pro-metastatic functions may provide insights for developing novel therapeutic approaches to strengthen BBB defenses and limit brain colonization in TNBC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.